Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer

2023Journal of Genetic Engineering and BiotechnologyJournalOpen access

10.1186/s43141-023-00498-6 Full text4 citations

Authors

6 authors across 2 institutions in 1 country.

Victor OmoboyedeFirst authorCorresponding
- Federal University of Technology (NG)
Ochapa Ibrahim
- Federal University of Technology (NG)
Haruna Isiyaku Umar
- Federal University of Technology (NG)
Grace Ayomide Oke
- Federal University of Technology (NG)
Olugbenga Samson Onile
- Elizade University (NG)
Prosper O. ChukwuemekaSenior author
- Federal University of Technology (NG)
as printed: Prosper Obed Chukwuemeka

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

FOXO transcription factor regulationlevel 3 · 0.12
Melanoma and MAPK Pathwayslevel 3 · 0.11
Computational Drug Discovery Methodslevel 3 · 0.05

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · Journal of Genetic Engineering and Biotechnology · 4 citations
https://openalex.org/W4367048075

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer · Sankore